Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
Clinical trial NCT04959201 · RECRUITING
Trial details
- NCT number
- NCT04959201
- Sponsor
- China Medical University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2026-12-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.